Shares of DuPont are richly valued

I'm placing a Hold on shares E.I. du Pont De Nemours (DD), also known as DuPont, first recommended on April 22, 2009 at a price of $27.48. If you bought DD in April, you're up about 20 percent.

Look for DD's coatings and color technologies business to begin to recover in 2010, on the U.S./global recoveries. However, DD's pharmaceuticals unit will face a tougher 2010, due to patent expirations. The First Call FY2009/FY2010 EPS estimates for DD are $2.01 to $2.22.
Why the Hold rating? Valuation. Until the pharmaceuticals division shows signs of increased earnings and emerging market food demand accelerates - something that would increase DD's sales of seeds - DD's shares look slightly rich at $33. In a few months, I've re-evaluate DuPont's performance and stock valuation.

Technically, DuPont's stock chart has formed a short-term double top, which could turn into a head-and-shoulders top – each of which is a bearish signal.

Finally, the Sell/Stop Loss has been raised to $28, or to just above cost, to protect against any retrenchment in the shares.

Stock Analysis: Don't Buy DuPont's shares at this time. If you bought shares in April, Hold the shares. Revised Sell/Stop Loss: $28.

Disclosure: Lazzaro has no positions in stocks, but does own shares in two Pimco Bond Funds: PHDAX and PYMAX.

Read Full Story

Markets

NASDAQ 6,889.16 21.80 0.32%
S&P 500 2,602.42 5.34 0.21%
DJIA 23,557.99 31.81 0.14%
NIKKEI 225 22,550.85 27.70 0.12%
HANG SENG 29,866.32 158.38 0.53%
DAX 13,059.84 51.29 0.39%
USD (per EUR) 1.19 0.01 0.71%
USD (per CHF) 0.98 0.00 -0.23%
JPY (per USD) 111.51 0.27 0.25%
GBP (per USD) 1.33 0.00 0.25%

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.